Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations

Clinical trial NCT01979484 · COMPLETED

Trial details

NCT number: NCT01979484
Sponsor: Presidio Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetic Assessments in Healthy Volunteers

Start date: 2013-10-01
Primary completion: 2013-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.